Arvee Laboratories (India) Limited Stock Price Today (NSE: ARVEE)
Fundamental Score
Arvee Laboratories (India) Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Arvee Laboratories (India) Limited share price today is ₹195.25, down 7.15% on NSE/BSE as of 10 September 2026. Arvee Laboratories (India) Limited (ARVEE) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹215.17 (Cr). The 52-week high for ARVEE share price is ₹290.78 and the 52-week low is ₹129.11. At a P/E ratio of 53.06x, ARVEE is currently trading above its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 7.77% and a debt-to-equity ratio of 0.03.
Arvee Laboratories (India) Limited Share Price Chart — NSE/BSE Historical Performance
Arvee Laboratories (India) Limited share price chart: 24.91% return over the past month. 52-week high ₹290.78, 52-week low ₹129.11.
Arvee Laboratories (India) Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹206.00 | ₹224.99 | ₹206.00 | ₹210.29 | 1.59L (Cr) | |
| ₹164.74 | ₹196.71 | ₹163.61 | ₹193.74 | 59.14K (Cr) | |
| ₹162.20 | ₹169.15 | ₹162.20 | ₹163.93 | 697.00 (Cr) | |
| ₹165.61 | ₹171.90 | ₹163.00 | ₹165.10 | 790.00 (Cr) | |
| ₹167.46 | ₹173.37 | ₹165.00 | ₹165.00 | 1.08K (Cr) | |
| ₹164.01 | ₹166.80 | ₹163.39 | ₹165.81 | 962.00 (Cr) | |
| ₹168.48 | ₹168.50 | ₹163.80 | ₹164.21 | 1.15K (Cr) | |
| ₹174.00 | ₹175.11 | ₹162.56 | ₹168.48 | 1.93K (Cr) | |
| ₹162.15 | ₹174.50 | ₹162.15 | ₹169.00 | 823.00 (Cr) | |
| ₹174.00 | ₹174.40 | ₹164.25 | ₹170.59 | 3.03K (Cr) |
Arvee Laboratories (India) Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹168.48 | ₹224.99 | ₹162.20 | ₹210.29 | +24.82% | |
| ₹156.72 | ₹189.99 | ₹153.85 | ₹168.48 | +7.50% | |
| ₹164.20 | ₹174.80 | ₹147.15 | ₹156.72 | -4.56% | |
| ₹160.01 | ₹189.89 | ₹155.40 | ₹165.55 | +3.46% | |
| ₹168.00 | ₹176.00 | ₹147.15 | ₹165.23 | -1.65% | |
| ₹141.20 | ₹186.19 | ₹130.40 | ₹168.00 | +18.98% | |
| ₹150.00 | ₹160.00 | ₹129.11 | ₹133.86 | -10.76% | |
| ₹160.00 | ₹172.00 | ₹151.55 | ₹155.00 | -3.13% | |
| ₹213.33 | ₹221.50 | ₹146.50 | ₹156.88 | -26.46% | |
| ₹165.00 | ₹290.78 | ₹158.14 | ₹213.33 | +29.29% | |
| ₹164.00 | ₹175.75 | ₹155.00 | ₹160.54 | -2.11% | |
| ₹155.40 | ₹170.00 | ₹153.00 | ₹163.61 | +5.28% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Arvee Laboratories (India) Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Arvee Laboratories (India) Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of ARVEE across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Robust Profit Growth (901.89%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (130.28%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.03)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (11.35x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 3.35)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (73.50%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
9 factors identified
Below-Average Return on Equity (7.77%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (7.69%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Premium Valuation Risk (P/E: 53.06x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
High Price-to-Book Ratio (6.37x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Limited Growth History (-7.83% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Earnings Growth (-1.18% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Stagnant Profit Growth (-1.15% CAGR)
Observation: Limited 5-year profit growth trajectory.
Analysis: Low profit growth may indicate scalability challenges or market maturity.
Negative Free Cash Flow (₹-4.15 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Arvee Laboratories (India) Limited vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Arvee Laboratories (India) Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
38.4/100 | ₹195.25₹195 | ₹215.17₹215.17 | 53.06Average 53.1 Average | 7.77%Poor 7.77% Poor | 7.69%Poor 7.69% Poor | 0.03Excellent 0.0 Excellent | -1.15%Poor -1.15% Poor | -7.83%Poor -7.83% Poor | 0.00% | |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1573.50₹1574 | ₹160150.83₹160150.83 | 60.47Average 60.5 Average | 23.79%Excellent 23.79% Excellent | 29.92%Excellent 29.92% Excellent | 0.01Excellent 0.0 Excellent | 16.70%Excellent 16.70% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LimitedGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4683.60₹4684 | ₹51519.60₹51519.60 | 84.10Average 84.1 Average | 7.65%Poor 7.65% Poor | 10.87%Average 10.87% Average | 0.28Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LimitedNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹8858.00₹8858 | ₹45441.54₹45441.54 | 57.45Average 57.5 Average | 20.11%Excellent 20.11% Excellent | 21.48%Excellent 21.48% Excellent | 0.31Excellent 0.3 Excellent | 20.84%Excellent 20.84% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LimitedDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1665.00₹1665 | ₹22710.60₹22710.60 | 28.99Average 29.0 Average | 9.81%Poor 9.81% Poor | 11.31%Average 11.31% Average | 0.26Excellent 0.3 Excellent | -6.63%Poor -6.63% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LimitedAether Industri... AETHER • 543534 | 36.3/100 | ₹1633.30₹1633 | ₹21676.01₹21676.01 | 91.91Average 91.9 Average | 9.38%Poor 9.38% Poor | 12.78%Average 12.78% Average | 0.18Excellent 0.2 Excellent | — — | — — | 0.00% |
Atul LimitedAtul Limited... ATUL • 500027 | 58.2/100 | ₹6282.00₹6282 | ₹18494.21₹18494.21 | 23.25Average 23.3 Average | 11.47%Average 11.47% Average | 14.24%Average 14.24% Average | 0.03Excellent 0.0 Excellent | 54.89%Excellent 54.89% Excellent | 10.95%Good 10.95% Good | 0.49% |
Aarti Industries LimitedAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹497.95₹498 | ₹18061.64₹18061.64 | 34.01Average 34.0 Average | 7.25%Poor 7.25% Poor | 8.86%Poor 8.86% Poor | 0.83Good 0.8 Good | -4.35%Poor -4.35% Poor | 12.96%Good 12.96% Good | 0.20% |
BASF India LimitedBASF India Limi... BASF • 500042 | 52.2/100 | ₹3802.00₹3802 | ₹16458.86₹16458.86 | 25.57Average 25.6 Average | 0.00%Poor 0.00% Poor | 14.04%Average 14.04% Average | 0.00Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.35%Good 9.35% Good | 0.68% |
Fine Organic Industries LimitedFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹5145.00₹5145 | ₹15774.57₹15774.57 | 36.01Average 36.0 Average | 16.82%Good 16.82% Good | 21.91%Excellent 21.91% Excellent | 0.02Excellent 0.0 Excellent | 28.23%Excellent 28.23% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LimitedAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1224.50₹1225 | ₹13940.69₹13940.69 | 79.62Average 79.6 Average | 5.50%Poor 5.50% Poor | 9.10%Poor 9.10% Poor | 0.54Good 0.5 Good | 19.33%Excellent 19.33% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price160150.83 Cr
- Gujarat Fluorochemicals Limited share price51519.60 Cr
- Navin Fluorine International Limited share price45441.54 Cr
- Deepak Nitrite Limited share price22710.60 Cr
- Aether Industries Limited share price21676.01 Cr
Arvee Laboratories (India) Limited PE Ratio History
Historical price-to-earnings ratio for ARVEE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹0.95 | ₹173.77 | 182.9x |
| FY 2023 | ₹3.74 | ₹172.95 | 46.2x |
| FY 2022 | ₹2.34 | ₹129.65 | 55.4x |
| FY 2021 | ₹3.24 | ₹87.25 | 26.9x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Arvee Laboratories (India) Limited Quarterly Performance
Latest quarterly metrics for ARVEE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
130.28%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
901.89%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-7.83%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
-1.15%
Compounded annual net profit growth over 5 years
Arvee Laboratories (India) Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for ARVEE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Arvee Laboratories (India) Limited Financial Statements
Annual income statement, balance sheet and cash flow for Arvee Laboratories (India) Limited (ARVEE) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Arvee Laboratories (India) Limited
About ARVEE (Arvee Laboratories (India) Limited)
Arvee Laboratories India Ltd is a pioneering force in the realm of specialty chemicals, crafting innovative solutions that cater to a diverse range of industrial applications. At t...he heart of their operations lies a commitment to precision and quality, manufacturing complex molecules with exacting standards. Their portfolio showcases a deep understanding of chemical synthesis, producing specialized intermediates and fine chemicals that serve as crucial building blocks for various downstream industries. Through meticulous research and development, Arvee Laboratories is constantly pushing the boundaries of chemical innovation, forging new pathways to enhance product performance and efficiency across various sectors. Their dedication to customer satisfaction and technical expertise makes them a trusted partner for businesses seeking tailored chemical solutions. The company's focus centers on delivering high-performance chemicals that address specific industry needs, particularly in the areas of polymers and imaging. Their specialized offerings play a critical role in modifying and enhancing the properties of polymers, contributing to improved durability, flexibility, and overall performance in diverse applications. They also cater to the medical imaging sector, providing key intermediates used in the production of contrast media agents. These compounds enable clearer and more detailed medical imaging, thereby aiding in accurate diagnoses. Arvee Laboratories' dedication to both polymer modification and medical imaging underscores their commitment to supporting advancements in materials science and healthcare. Arvee Laboratories India Ltd prides itself on its state-of-the-art manufacturing facilities and a highly skilled workforce dedicated to upholding the highest quality standards. Their manufacturing processes adhere to strict environmental and safety regulations, ensuring responsible and sustainable chemical production. By leveraging advanced technology and continuous improvement initiatives, Arvee Laboratories strives to optimize its operations and minimize its environmental footprint. The company's unwavering commitment to excellence, combined with its strong focus on customer collaboration, positions it as a reliable and innovative provider of specialty chemicals in the Indian market and beyond.
Company Details
Key Leadership
ARVEE Share Price: Frequently Asked Questions
What is the current share price of Arvee Laboratories (India) Limited?
Arvee Laboratories (India) Limited (ARVEE) trades at ₹195.25 on NSE. Market cap ₹215.17 (Cr). Educational data only.
What is the P/E ratio of Arvee Laboratories (India) Limited?
Arvee Laboratories (India) Limited has a P/E of 53.06x vs industry average 31.95x.
What is the Bull Run score for Arvee Laboratories (India) Limited?
Arvee Laboratories (India) Limited has a Bull Run score of 38.4/100 based on 25+ financial parameters.
Does Arvee Laboratories (India) Limited pay dividends?
Arvee Laboratories (India) Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Arvee Laboratories (India) Limited?
Arvee Laboratories (India) Limited has ROE of 7.77%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Arvee Laboratories (India) Limited?
Arvee Laboratories (India) Limited has debt-to-equity of 0.03.
Is Arvee Laboratories (India) Limited a good investment?
Bull Run gives Arvee Laboratories (India) Limited a score of 38.4/100. This is not investment advice — consult a SEBI-registered advisor.